7XY.F SWEDENCARE AB O.N.
- Market cap
- EUR 267M
- P/E
- 33.4x
- P/B
- 0.39x
- ROE
- 1.3%
- Dividend yield
- 1.52%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 7XY.F undervalued?
Graham number7XY.F trades 23.5% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
SWEDENCARE AB O.N. fundamental analysis
No fundamental analysis for SWEDENCARE AB O.N. yet.
SWEDENCARE AB O.N. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About SWEDENCARE AB O.N.
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, u…
Full company profileSWEDENCARE AB O.N. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
SWEDENCARE AB O.N. annual financial statements (SEK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.84B | 2.34B | 2.53B | 2.68B | 2.75B |
| Gross Profit | 1.03B | 1.29B | 1.45B | 1.51B | 1.66B |
| Operating Income | 120M | 179M | 222M | 137M | 234M |
| EBITDA | 390M | 484M | 549M | 452M | 555M |
| Net Income | 94.5M | 58.6M | 98.9M | 55.5M | 93.5M |
| EPS | 0.60 | 0.37 | 0.62 | 0.35 | 0.58 |
| Balance Sheet | |||||
| Total Assets | 10.0B | 9.52B | 10.3B | 9.51B | 10.2B |
| Total Liabilities | 2.54B | 2.32B | 2.28B | 2.84B | 2.84B |
| Shareholders' Equity | 7.46B | 7.21B | 8.03B | 6.66B | 7.35B |
| Cash & Short-term Investments | 245M | 237M | 187M | 103M | 91.2M |
| Cash Flow | |||||
| Operating Cash Flow | 260M | 444M | 359M | 327M | 320M |
| Capital Expenditure | 74.7M | 36.1M | 71.3M | 51.2M | 72.7M |
| Free Cash Flow | 186M | 408M | 288M | 276M | 247M |
| Ratios | |||||
| ROE | 1.3% | 0.8% | 1.2% | 0.8% | 1.3% |
| ROA | 0.9% | 0.6% | 1.0% | 0.6% | 0.9% |
| Net Profit Margin | 5.1% | 2.5% | 3.9% | 2.1% | 3.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
SWEDENCARE AB O.N. dividends
- Dividend yield
- 1.52%
- Forward dividend
- 0.03 EUR
- Payout ratio
- 72.1%
- Ex-dividend date
- Apr 24, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | SEK 40.0M | 0.25 | 72.1% |
| 2024 | SEK 36.5M | 0.23 | 36.9% |
| 2023 | SEK 34.9M | 0.22 | 59.6% |
| 2022 | SEK 31.6M | 0.20 | 33.4% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns SWEDENCARE AB O.N.
- Insiders 67.26%
- Institutions 22.38%
- Public & others 10.37%
- Shares outstanding 160M
- Free float 52.4M
SWEDENCARE AB O.N. company profile
- Company name
- SWEDENCARE AB O.N.
- Ticker
- 7XY.F
- ISIN
- SE0015988167
- Exchange
- Frankfurt Exchange
- Sector
- Consumer Defensive
- Industry
- Pharmaceuticals
- Employees
- 589
- Fiscal year end
- December
- Address
- Medeon Science Park, Malmö, Sweden, 205 12
- Phone
- 46 4 08 59 33
- Website
- swedencare.com
About SWEDENCARE AB O.N.
Swedencare AB (publ), together with its subsidiaries, develops, manufactures, markets, and sells animal healthcare products for cats, dogs, and horses in North America, Europe, and internationally. The company offers animal nutritional supplements, treats, and grooming products for dogs under the Healthy Breeds name; pet supplements and topical products for various therapeutic areas, such as orthopedics, behavior, dermatology, odontostomatology, algology, gastroenterology, urology, nephrology, and ophthalmology under the Innovet name; and support and solutions for the veterinary community under the Stratford Animal Health name. It also provides pet health supplements under the NaturVet, VETCLASSICS, and NutriScience name; pet supplements, vitamins, dental care products, ear cleaners, pilling agents, and topicals under the Pet MD name; and vet-formulated pet care products under the VetWELL name. In addition, the company offers dental product for dogs and cats under the ProDen PlaqueOff name; pharmaceutical grade health products for dogs, cats, and horses under the nutravet name; range of products to improve the health and life of pets under the Animal Pharmaceuticals name; dog treat offerings, such as jerky and baked biscuit, as well as nutritional supplements for skin and coat health, ear care, and liver support under the Riley's Organics name; and Rx Vitamins for Pets. The company distributes its products through veterinarians and pet stores, online, veterinary clinics and chains, pharmacy chains, as well as FDMC. Swedencare AB (publ) was incorporated in 1993 and is headquartered in Malmö, Sweden.
SWEDENCARE AB O.N. management
10- Mr. Hakan LagerbergChief Executive Officer · born 1968
- Ms. Jenny GraflindChief Financial Officer · born 1976
- Emma NordgrenIR & Communications Manager
- Mr. Brian NugentChief Commercial Officer of the North American Veterinary & Online Operations · born 1974
- Ms. Sabine UhdeHead of the Nordics-Swedencare Nordic AB · born 1970
- Mr. Laszlo VargaChief Commercial Officer of Europe
- Mr. Patrick PowellChief Operating Officer of Stratford Care & RX Vitamins Inc.
- James GarciaChief Commercial Officer of Swedencare USA
- Mr. Simon ShawHead of Ecommerce Europe
- Mr. Martin ShimkoCEO & MD of Swedencare USA Inc. · born 1964